-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
COVID-19 is a pandemic disease caused by SARS-CoV-2, which was initially characterized as the major respiratory syndrome.
COVID-19 medsci.
The effect of SARS-CoV-2 on heart cells derived from different types of ipsc.
The effect of SARS-CoV-2 on heart cells derived from different types of ipsc.
Human induced pluripotent stem cells were exposed to human induced pluripotent stem cells (iPSC) (iPSC) -derived heart cells exposed to SARS-CoV-2 SARS-CoV-2 , infection and effective transcriptome were found And morphological damage characteristics, especially in cardiomyocytes.
19-COVID COVID-19 in patients with cardiac dysfunction incidence reported in the range of obstacles to reporting the incidence of heart function in patients with a range of 20--50% 20--50% , regardless of the severity of the disease.
Original source
sciencemag.
sciencemag.
Leave a message here